-
1 Comment
HPGC Renmintongtai Pharmaceutical Corporation is currently in a long term downtrend where the price is trading 9.9% below its 200 day moving average.
From a valuation standpoint, the stock is 95.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.4.
HPGC Renmintongtai Pharmaceutical Corporation's total revenue rose by 5.9% to $2B since the same quarter in the previous year.
Its net income has dropped by 92.2% to $5M since the same quarter in the previous year.
Finally, its free cash flow grew by 116.3% to $17M since the same quarter in the previous year.
Based on the above factors, HPGC Renmintongtai Pharmaceutical Corporation gets an overall score of 3/5.
| Industry | Drug Manufacturers - Specialty & Generic |
|---|---|
| Exchange | SHG |
| CurrencyCode | CNY |
| ISIN | CNE000000G05 |
| Sector | Healthcare |
| PE Ratio | 23.32 |
|---|---|
| Target Price | None |
| Market Cap | 4B |
| Beta | 0.48 |
| Dividend Yield | None |
HPGC Renmintongtai Pharmaceutical Corporation engages in the wholesale and retail of pharmaceutical products in China. The company offers Chinese and Western patent medicines, Chinese herbal medicines, chemical preparations, antibiotics, biological products, biochemical drugs, medical devices, and health products, as well as tonic health, daily necessities, and cosmetics products. It also provides logistics services, including warehousing and distribution services; and hospital services comprising medical treatment, scientific research, prevention, health care, rehabilitation, and hemodialysis and kidney disease treatment. Further, it is involved in medical and commercial distribution, and third-terminal sales; and operation of Chinese medicine and outpatient clinics. It serves its products through e-commerce platform, a chain of direct stores and online B2C, O2O, WeChat mall mini programs, etc. The company was founded in 1950 and is headquartered in Harbin, China. HPGC Renmintongtai Pharmaceutical Corporation is a subsidiary of Harbin Pharmaceutical Group Co., Ltd.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 600829.SHG using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
